chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pain in the right side of my neck; Extreme weakness; This is a spontaneous report received from a contactable reporter A 71 year-old patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 13Mar2021 10:30 (Lot number: EN6206, Expiration Date: 30Jun2021) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Hyperthyroidism", start date: 1978 (ongoing), notes: Illness/AE: Hyperthyroidism, Stop date: Ongoing, Pertinent Details: Levothyroxine; "Abnormal electrical heart signals", stop date: 22May2021, notes: Illness/AE: Abnormal electrical heart signals, Onset date: Birth, Pertinent Details: SVT Ablation; "Cholesterol Build up", start date: Apr2019, stop date: 18Oct2019, notes: Illness/AE: Cholesterol Build up, Pertinent Details: Pravastatin 40mg; "Torn meniscus knee", start date: 09Jan2019, stop date: 12Aug2019, notes: Illness/AE: Torn meniscus knee, Pertinent Details: Knee surgery 2 months rehabilitation. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1st dose, Time: 10:15, Anatomical Site of injection: Left arm, Route of administration: Intramuscular, Batch/Lot number: EN6198, Exp date: 30Jun2021), administration date: 20Feb2021, for COVID-19 immunisation. The following information was reported: NECK PAIN (non-serious), outcome "recovered", described as "Pain in the right side of my neck"; ASTHENIA (non-serious) with onset 14Mar2021, outcome "recovered" (2021), described as "Extreme weakness". Therapeutic measures were not taken as a result of neck pain, asthenia.  Additional information: Reporter reported that he experience increase in heart rate the next day after vaccination on 21Feb2021- excess so he was stayed quiet and elevated in bed at 35% incline and slept for 4 hours Second vaccine caused pain in right side of in his neck and difficulty moving head to right use Voltaren arthritis rub and heat pad for a few hours since he was home care worker for my son who was a stroke victim I did not seek family doctor.  No follow-up attempts are possible. No further information is expected.
Patient presented with puncture wound requiring tetanus vaccine. We did not have Td vaccine available at this office, so patient was given at Dtap vaccine instead. Patient had some soreness at injection site, no other reports of adverse reactions or problems. No further treatment was given.
Had fever 2 days after vaccination, which went away after 24 hours. Was followed immediately by congestion and coughing. Was diagnosed as respiratory tract infection by pediatrician exactly 7 days after the vaccination. All this happened within 7 days of the vaccine. May or may not be caused by vaccine, but she was healthy before the vaccination.
Sleep: Insomnia, infection fungal, joint stiffness ache joint, amblyopia, arthritis, blood pressure varies blood in stool, bowels: Irritable, cramps leg, swelling: joints, stomatitis, ulcer "I have claim and disabilty on most of them" 8/27/07-records received. DX: Depression. Low back pain. Lipoma. Dermatophytosis of foot. Counseling on Substance Abuse. Colonic Polyps. Otitis Media with Effusion. Pharyngitis. Incipient senile cataract. Insomnia. Compression Fracture. Dermatitis. Moderate obstructive sleep apnea. C/O insomnia, fell sad, frustrated, guilty, hopeless and low of energy. Daily alcohol consumption. NCVs Changes notes on sensory NCS could be present in early sensory peripheral neuropathy.
24h after 2nd shot (when I woke up in the morning) chest/heart pain. Sharp pain similar to a side stitch. I slept and rested during the day.  48h after 2nd shot, chest/heart tickling but no pain anymore.
Within 45 minutes had some dizziness,  fatigue, woke up with left eye drooping and swollen down into cheekbone area, with a little blurry vision.
The patient received her annual Influenza Vaccine (FLUZONE) on 9/24/13. She was in her normal state of good health at the time. Approximately 30-60 minutes after receipt of the vaccination the patient noted generalized itching and hives on her arms, legs and chest. She returned to medical and was given BENADRYL po and placed in quarters. According to the patient when she awoke a few hours later the itching and the majority of the hives had resolved. The patient denies symptoms of difficulty breathing/swallowing, angioedema, lightheadedness, palpitations, sneezing, rhinorrhea, cough, clearing of her throat, abdominal pain, nausea, vomiting or diarrhea. Previously, the patient received AFLURIA on 9/26/12 and FLUMIST on 10/3/11 without adverse event. The patient states that she had never received an Influenza vaccination prior to entry. Of note, her history is positive for the sensation of "throat tightening" after eating lightly cooked eggs. The patient does not eat foods with egg like potato salad or meringue; she is able to eat baked goods with eggs without issue.
30 potential patients received thawed, refrozen, thawed again vaccine doses; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT STORAGE ERROR (30 potential patients received thawed, refrozen, thawed again vaccine doses) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939906) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Oct-2021, the patient experienced PRODUCT STORAGE ERROR (30 potential patients received thawed, refrozen, thawed again vaccine doses). At the time of the report, PRODUCT STORAGE ERROR (30 potential patients received thawed, refrozen, thawed again vaccine doses) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was provided by the reporter.  No treatment medications was provided by the reporter.  As the Source document product was removed from freezer and thawed and kept in refrigerator and again was replaced in freezer, sat for overnight later this product vaccine was administered to 30 patients.
Next day, bruises started to appear on the left side of patient's body.  Bruises around and below injection site with swelling, bruises below injection site, on stomach, knee area, and foot.  Pt came in today 4/28 stating bruises are going away and no new bruise sites are appearing.
This case was reported by a consumer and described the occurrence of dizziness in an unknown number of subjects of unspecified ages and gender who were vaccinated with Influenza vaccine (manufacturer unspecified). A physician or other health care professional has not verified this report. In 2007, the subjects received unspecified doses of Influenza vaccine (unknown). The reporter stated he "talked with numerous people who have experienced dizziness, inner ear problems, nausea and vomiting after receiving the flu shot this year". At the time of reporting the outcome of the events were unspecified.
On 03-20-03, day 7 post-vaccination, this primary vaccinee was noted to have several open skin tears and erythema surrounding the vaccination site with swelling of the arm distal from the vaccination site to slightly above the elbow.  Also reported swollen lymph nodes in the left axilla.  Vaccinee was advised to discontinue use of the semipermeable dressing and use gauze dressing until skin tears healed.  On day 8, reported use of hypoallergenic semipermeable dressing with decrease in erythema.  On 03-23-03, day 10 post-vaccination, vaccinee presented to local ER due to complaint of pain, intense itching, increased redness and swelling surrounding the vaccination site.  Vaccinee also reported sore mouth and throat described as feeling like ulcers.  Medical records indicate vaccinee was afrebrile with normal CBC; physical exam was reported significant for left axillary adenopathy, with a tender, swollen, reddened "band" with mild calor surrounding the vaccination site and encircling the left upper arm.  Diagnosis was recorded as "variant reaction to smallpox vaccination" with discharge home with prescription for Vicodin as needed for pain.  Assessment on day 14 post-vaccination revealed decrease in swelling and redness surrounding the site, lymph nodes in left axilla remained swollen but decrease in tenderness was reported.  Two new skin tears noted due to use of paper tape, previous skin tears healing.  Vaccinee reported now using gauze secured with "Kerlix type" wrap. By day 18 post-vaccination, swelling of arm and lymph nodes had resolved,  reported systemic symptoms resolved, minimal erythema noted surrounding the vaccination site, skin tears almost healed; vaccination site with scabbed lesion.
Pt arrives to the observation area after receiving her vaccine.  she states she got nauseous after the injection, shakey, and was seeing spots. 1805 BP 101/ 57 HR 78 Oxygen sat 99% room air pt was given juice upon arrival 1810 BP 114/60 HR 86 oxygen 99% pt states she feels better after the sips of juice 1815  laying BP 106/59  HR 77  oxygen sat 100% room air sitting BP 111/70 HR 70 oxygen sat 100 % room air standing 112/ 65 HR 79 oxygen sat 100 % room air pt feeling better and wants to go 1818 pt was released from observation and escorted to the exit with staff.
I experienced sore throat, fatigue and a breakthrough case of COVID-19 that lasted for 8 days then I tested negative.
Shot given on Jan 5.  Head ache started within 15 minutes.  Neuropathy pain in my hands within 45 minutes.  Woke in morning (Jan 6th) with the left side of my face numb. Headache persisted.  Felt sick, fatigued.  On Jan 7th I had some shortness of breath, continued head ache, continued facial numbness, sickness, and brain fog.  In the days since my face is intermittently numb.  I have continued to feel ill, have brain fog, head aches and neuropathy in my ankle and on my upper thighs (intermittently).
high grade fever started 12 hours after dose and managed by Tylenol 500mg; this lasted for 24 hours after 1st onset. headache started 6 hours after dose administration and managed by Tylenol. joint and muscle ache started 6 hours later to dose and still  dizziness. injection site sore; still hurting.
Late period (had previous period end on 8-17-21, this period started on 8-27-22), period has always been regular and no reason for a late period
Patient emailed this nurse stating  she noticed a red rash near injection site on 10/16/2022. States the rash is itchy an slightly warm. She denies any fevers, SOB, nausea, vomiting, diarrhea, an body aches. Communication has been sent to  provider regarding this.
pt recvd vax 3SPE93 & on 13SEP93 came in to office w/fever & rash that had devel the 8th day p/vax;
sweating; shivering; fever of 101.9 degrees; pain at the injection site; body aches; This case was reported by a consumer and described the occurrence of sweating in a 67-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2019-2020 season) for prophylaxis.   In December 2019, the patient received the 1st dose of Shingrix (intramuscular) and the 1st dose of Influenza vaccine Quadrivalent 2019-2020 season (intramuscular). In December 2019, less than a day after receiving Shingrix and Influenza vaccine Quadrivalent 2019-2020 season, the patient experienced sweating, shivering, fever, injection site pain and general body pain. On an unknown date, the outcome of the sweating, shivering, fever, injection site pain and general body pain were recovered/resolved.   It was unknown if the reporter considered the sweating, shivering, fever, injection site pain and general body pain to be related to Shingrix and Influenza vaccine Quadrivalent 2019-2020 season.  Additional details were provided as follows: The patient received 1st dose of Shingrix and vaccine Quadrivalent 2019-2020 season in left arm. In December 2019, the patient underwent body temperature test which results 101.9 degree F. After receiving 1st dose of Shingrix, the patient experienced body aches, pain at the injection site, shivering, sweating, and a fever. In March 2020, the patient had 2nd dose of Shingrix. The reporter did not consent to follow up. This case has been linked with US2020244471 and US2020AMR245444, reported by same reporter and same patient.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020244471:same reporter US-GLAXOSMITHKLINE-US2020AMR245444:same reporter
After my 2nd COVID 19 Pfizer vaccine, I found a big nodule at my right thyroid area. I also had following symptoms: 1. depression and mode swing with suicidal attempts, 2. sudden confusion or loss of immediate memory, such as forgetting close friends? name and losing keys, 3. tired very easily, 4. loose hair severely, 6. Intolerance to coldness, and 7. blurred vision in the morning. I went to see my family doctor and endocrinologist. My endocrinologist diagnosed me with Hashimoto thyroiditis and Thyroid goiter.
Patient reports back on the side of spine (right lumbar pressure). Patient reports a lot of pressure, and cannot move. Patient took Tylenol before vaccination at 10AM and was vaccinated at 11AM. Patient reports pain starting when she tried to bend down to get a dress. Then the patient experienced sharp pain thereafter where she cannot stand or move.
The way in which vaccine was administered made her bleed; injection site was bleeding a lot; injection site swelling; A spontaneous report was received from a consumer concerning an unspecified patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and experienced the way in which vaccine was administered made her bleed, injection site was bleeding a lot, and injection site swelling.  The patient's medical history was not provided. No relevant concomitant medications were reported.   On 12 Jan 2021, approximately 0 days prior to the onset of the events, the patient received a dose of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.  On 12 Jan 2021, the patient reported the way the vaccine was administered made her bleed profusely and she stated she had never seen that much blood. She also reported the injection site was swelling because of the way the vaccine was administered. No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.  The event, the way in which vaccine was administered made her bleed, was considered on 12 Jan 2021. The outcomes of the events, injection site was bleeding a lot, and injection site swelling were unknown.; Reporter's Comments: This case concerns a female patient of an unknown age. The patient's medical history and concomitant medications were not provided. The patient experienced a non serious event of the way in which vaccine was administered made her bleed, injection site was bleeding a lot, and injection site swelling.The event occurred on the same day as the first dose of the mRNA-1273. Very limited information regarding these events have been provided at this time. Based on temporal association between the use of mRNA-1273 and the events, a causal relationship cannot be excluded. Additional information is required for further assessment.
Mild: Lethargy, weakness. Moderate: Injection site very sore. Severe: Palpitations/flutters of mitral valve. I normally experience perhaps 1 heart flutter a week, maybe less, as result of prolapsed mitral valve. For 2 full days after vaccine, I experienced flutter/missed beats at least 10 an hour, sometimes more.
After H1N1 vaccine Rt upper arm experienced large induration. Persisting for greater than 1yr with muscle weakness & pain.
Pt reports that he has a sore Right Arm since Vaccination and it is difficult to raise that arm.
This case was reported by a other health professional via call center representative and described the occurrence of shingles in a 70-year-old female patient who received SHINGRIX (batch number 3374S, expiry date 22nd November 2020) for prophylaxis. Co-suspect products included FLUAD for prophylaxis. On 17th October 2018, the patient received SHINGRIX. In October 2018, the patient received FLUAD. On 20th October 2018, 3 days after receiving SHINGRIX, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown. It was unknown if the reporter considered the shingles to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. It was stated that, the patient experienced shingles approximately 14 days after vaccination with FLUAD. It was unknown if the reporter considered the shingles to be related to FLUAD as well. The reporter consented to follow up.
Aching sore arm about 5 hours after vaccines given (pneumo PS & Tdap), tender (L). deltoid - no swelling, a little warm, sniffling, throat normal, TM's normal. Likely (rare) systemic reaction to either vaccine. Ibuprofen or TYLENOL as needed. Return to clinic if persistent.
(mother positive first), Sx onset 7/18/21 cough, runny nose, chills, headache, muscle aches, loss of smell & loss of taste.
Shot received 6/14/17. Fevers 6/15/17 (morning). Red spot/stopped putting pressure on leg 6/15/17 (afternoon). Dr. appt 6/16/17.
a staff member hit her in her right arm, right arm had been hurting ever since then; This is a spontaneous report from a contactable consumer (patient). A 59-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), second dose via an unspecified route of administration, administered in right arm on 14Apr2021 13:00 (Lot Number: EP7534, Expiration date: Jul2021) as single dose for covid-19 immunisation. Medical history included lupus from 2019. Patient was diagnosed with lupus of the skin and bones in 2019. She said she got infusions for the lupus in her left arm. Concomitant medication(s) was not reported. Patient previously received BNT162B2 (Lot Number: EN6205, Expiration Date: Jun2021) first dose administered in right arm on 26Mar2021 for covid-19 immunisation. On14Apr2021, patient went to work afterwards, and a staff member hit her in her (right) arm (around 6:00PM). She said her right arm had been hurting ever since then. She said she took Tylenol and put alcohol on her arm, but she was still having pain (clarifying her right arm hurts when she tried to lift it). Patient took a Tylenol (Lot Number: 30035519, Expiration Date: Jul2022) 325mg tablet that was dispensed in a little packet from her job (mental hospital). Stated she did not see a NDC Number, providing number SDC002. Patient stated when got home from work, she applied Alcohol to her right arm. She stated she was not sure if the first character in the Alcohol 50% Lot Number was an "8" or "0". Reported she was right-handed and had got both COVID-19 Vaccine doses in her right arm. She said she didn't use her left arm because she got infusions in her left arm for her lupus of the skin and bone. Patient stated she had no problem with the COVID-19 Vaccine, until she was hit in the arm she received the COVID-19 Vaccine in. A sample of the product was available to be returned, if requested. The event outcome was not recovered.  No follow-up attempts are possible. No further information is expected
TDAP was given unnecessarily, patient had received one last year. Medical assistant  got TDAP instead of HEP B vaccine from the fridge. Patient was informed.
Patient began to experience throat and chest tightness 15 minutes post vaccine. She reported to UC for further evaluation, symptoms began to resolve without taking anything appox. 1 hour after vaccine.
This spontaneous report was received from a social media user, as part of a marketing research program and refers to a male patient of unknown age. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On an unknown date, the patient was vaccinated with GARDASIL injection (exact dose, dose number, route of administration, anatomical location, lot # and expiration date were not reported). On an unknown date, the patient experienced inability to gain and erection within weeks of the GARDASIL. The outcome of the event was unknown. The reporter considered the event to be related to GARDASIL. This is one of several reports received from the same reporter. Additional information has been requested.
received her 3rd dose of the Pfizer-Biontech Covid19 vaccine, yesterday (19Aug2021); received her 3rd dose of the Pfizer-Biontech Covid19 vaccine, yesterday (19Aug2021); felt a little heat in her body; my arm was sore; immune compromised; This is a spontaneous report from a contactable consumer (patient) via medical information team. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Lot number: unknown, Expiry date: unknown), via an unspecified route of administration on 19Aug2021 as dose 3, single for covid-19 immunization. Medical history included immune disorder and alcohol abuse (has a drink after work) from an unspecified date and unknown if ongoing. Concomitant medications were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Lot number: not reported) as dose 1, single and dose 2, single both via an unspecified route of administration on an unspecified date for covid-19 immunization and experienced sore arm for both the doses. It was reported that, Patient received her 3rd dose of the Pfizer-Biontech Covid19 vaccine, yesterday (19Aug2021) and she was immune-compromised and "my arm was sore" no other symptoms on an unspecified date in Aug2021. She absolutely felt fine on the day. She also felt a little heat in her body on 19Aug2021, but she did not have a fever. She knew it could be normal to have a little temperature after getting the COVID 19 vaccine.  Reporter stated that her mother, who had the same immune disorder, received a 3rd dose the same day but at a different location, and was told not to drink for at least the first day. Also stated she was definitely one of those people who had a drink or two every night, she went to a party last night and had 3 glasses of wine that night after receiving her 3rd dose. She would like to know if consuming alcohol would affect the vaccines efficacy. After the party she was feeling revved up so she took a sleeping pill and slept. Outcome of the events "my arm was sore", felt a little heat in her body and immune compromised was recovered on an unspecified date in Aug2021.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up  Follow up (02Sep2021): New information received from a contactable consumer. This consumer reported in response to non-HCP letter sent via telephonic follow-up activity which included that: Consumer provided mailing address.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow-up.  Follow-up (13Oct2021): This follow-up is being submitted to notify that the batch/lot number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Immediate tinnitus following vaccine. It hasn't let up in over a year. Still ongoing, constant.
This is a 47-year-old I am asked to see. She received 2 shots on 2/22/2018. These were hepatitis B #3 and a MENACTRA vaccine, both of which she had previously received. She reports that the next day she developed swelling in the left upper arm at the site were both shots have been given.  This was associated with general unwellness and she says "I thought I was going to die". She reports a measured fever of 101F. She had aches and pains all over. She did not have any coexisting upper respiratory symptoms are cough and does not think that she developed a coincidental infection.